Cingulate Inc. (CING) stock
CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
$4.72+0.97 (+25.87%)
Close on Nov 17, 2026Market cap $68.64MP/E –Yield –
Cingulate shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Cingulate's shares outstanding was 13M at Jun 30, 2026. For fiscal 2025 it was 5M, up 231.5% from the year before. The highest annual figure on record is 5M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5M | +231.5% |
| FY2024 | Dec 31, 2024 | 2M | +1921.3% |
| FY2023 | Dec 31, 2023 | 0M | -87.5% |
| FY2022 | Dec 31, 2022 | 1M | +51.7% |
| FY2021 | Dec 31, 2021 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 13M | +200.4% |
| Q1 FY2026 | Mar 31, 2026 | 10M | +168.1% |
| Q4 FY2025 | Dec 31, 2025 | 7M | +1534.0% |
| Q3 FY2025 | Sep 30, 2025 | 5M | +4310.6% |
| Q2 FY2025 | Jun 30, 2025 | 4M | +5229.5% |
| Q1 FY2025 | Mar 31, 2025 | 4M | +274.2% |
| Q1 FY2024 | Mar 31, 2024 | 0M | -27.1% |
| Q4 FY2023 | Dec 31, 2023 | 0M | -79.2% |
| Q3 FY2023 | Sep 30, 2023 | 0M | -86.4% |
| Q2 FY2023 | Jun 30, 2023 | 1M | +60.9% |
| Q1 FY2023 | Mar 31, 2023 | 1M | -6.7% |
| Q4 FY2022 | Dec 31, 2022 | 1M | – |
| Q3 FY2022 | Sep 30, 2022 | 1M | – |
| Q2 FY2022 | Jun 30, 2022 | 1M | – |
| Q1 FY2022 | Mar 31, 2022 | 1M | – |
See a number that looks wrong?